Back to Search
Start Over
Large Between-Patient Variability in eGFR Decline before Clinical Trial Enrollment and Impact on Atrasentan’s Efficacy
- Source :
- Journal of the American Society of Nephrology, 32(11), 2731-2734. AMER SOC NEPHROLOGY, JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA, instname, Journal of the American Society of Nephrology, Journal of the American Society of Nephrology, 32(11), 2731-2734. American Society of Nephrology
- Publication Year :
- 2021
-
Abstract
- n/a.
- Subjects :
- Oncology
medicine.medical_specialty
MEDLINE
eGFR decline
Type 2 diabetes
Egfr decline
endothelin receptor antagonist
law.invention
Randomized controlled trial
law
Internal medicine
Post-hoc analysis
medicine
business.industry
Endothelin receptor antagonist
Atrasentan
22/2 OA procedure
General Medicine
medicine.disease
Clinical trial
Nephrology
randomized controlled trial
type 2 diabetes
business
chronic kidney disease
medicine.drug
Subjects
Details
- Language :
- English
- ISSN :
- 10466673
- Volume :
- 32
- Issue :
- 11
- Database :
- OpenAIRE
- Journal :
- Journal of the American Society of Nephrology
- Accession number :
- edsair.doi.dedup.....cb9f86d3700d05af3717a2c720ef77fc
- Full Text :
- https://doi.org/10.1681/asn.2021040498